Telavancin is a semi-synthetic lipoglycopeptide antibiotic used to treat serious Gram-positive bacterial infections, including complicated skin and skin structure infections and hospital-acquired or ventilator-associated… Read more







Telavancin is a semi-synthetic lipoglycopeptide antibiotic used to treat serious Gram-positive bacterial infections, including complicated skin and skin structure infections and hospital-acquired or ventilator-associated bacterial pneumonia caused by susceptible organisms like methicillin-resistant Staphylococcus aureus. By inhibiting bacterial cell wall synthesis, it serves as a critical therapeutic option in clinical settings. This category contains high-quality reference standards of the Telavancin API, alongside related compounds such as pharmacopeial and non-pharmacopeial impurities, N-nitroso variants, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, analytical testing, and method validation to ensure drug efficacy and safety. By providing access to these specific metabolites and degradants, this collection supports precise quality control protocols and the maintenance of established pharmacopeial standards throughout the drug development and manufacturing lifecycle.